Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 981

The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.

Solid lipid nanoparticles

Mehnert, Wolfgang, Mäder, Karsten·2012·Advanced Drug Delivery Reviews

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.addr.2012.09.021

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 65

  1. Sandow, 1990, Pharmacokinetics and endocrine effects of slow release formulation of LHRH analogues, J. Steroid Biochem. Mol. Biol., 37, 925, 10.1016/0960-0760(90)90445-Q · doi:10.1016/0960-0760(90)90445-q
  2. Kopecek, 1999, HPMA copolymer-bound anticancer drugs: mechanism of action on cellular and subcellular levels, Proc. Int. Symp. Controlled Rel. Bioact. Mater., 26, 24
  3. Collins-Gold, 1990, Parenteral emulsions for drug delivery, Adv. Drug. Deliv. Rev., 5, 189, 10.1016/0169-409X(90)90016-L · doi:10.1016/0169-409x(90)90016-l
  4. Davis, 1974, Pharmaceutical aspects of intravenous fat emulsions, Am. J. Hosp. Pharm., 31, 149
  5. Müller, 1994, Fat emulsions for parenteral nutrition IV: Lipofundin MCT/LCT regimens for total parenteral nutrition (TPN) with high electrolyte load, Int. J. Pharm., 107, 121, 10.1016/0378-5173(94)90449-9 · doi:10.1016/0378-5173(94)90449-9
  6. Davis, 1987, Lipid emulsions as drug delivery systems, Ann. N.Y. Acad. Sci., 507, 75, 10.1111/j.1749-6632.1987.tb45793.x · doi:10.1111/j.1749-6632.1987.tb45793.x
  7. Graham, 1977, Thrombophlebitis after intravenous diazepam — can it be prevented, Anesth. Analg., 56, 409, 10.1213/00000539-197705000-00020 · doi:10.1213/00000539-197705000-00020
  8. Domb, 1995, Long acting injectable oxytetracycline-liposphere formulation, Int. J. Pharm., 124, 271, 10.1016/0378-5173(95)00098-4 · doi:10.1016/0378-5173(95)00098-4
  9. Domb, 1993, Liposphere parenteral delivery system, Proc. Intern. Symp. Control. Rel. Bioact. Mater., 20, 346
  10. Siekmann, 1992, Submicron-sized parenteral carrier systems based on solid lipids, Pharm. Pharmacol. Lett., 1, 123
  11. Cavalli, 1993, Solid lipospheres of doxorubicin and idarubicin, Int. J. Pharm., 89, R9, 10.1016/0378-5173(93)90313-5 · doi:10.1016/0378-5173(93)90313-5
  12. zur Mühlen, 1998, Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles, Pharmazie, 53, 552
  13. Siekmann, 1994, Melt-homogenized solid lipid nanoparticles stabilized by the nonionic surfactant tyloxapol. I. Preparation and particle size determination, Pharm. Pharmacol. Lett., 3, 194
  14. A. zur Mühlen, Feste Lipid-Nanopartikel mit prolongierter Wirkstoffliberation: Herstellung, Langzeitstabilität, Charakterisierung, Freisetzungsverhalten und mechanismen, Ph.D. Thesis, Free University of Berlin, 1996.
  15. Gasco, 1997, Solid lipid nanospheres from warm micro-emulsions, Pharm. Tech. Eur., 9, 52
  16. Boltri, 1993, Lipid nanoparticles: Evaluation of some critical formulation parameters, Proc. Intern. Symp. Control. Rel. Bioact. Mater., 20, 346
  17. De Labouret, 1995, Application of an original process for obtaining colloidal dispersions of some coating polymers. Preparation, characterization, industrial scaling up, Drug Dev. Ind. Pharm., 21, 229, 10.3109/03639049509048106 · doi:10.3109/03639049509048106
  18. Gasco, 1992, Optimization of the incorporation of desoxycortisone acetate in lipospheres, Eur. J. Pharm. Biopharm., 38, 7
  19. C. Schwarz, Feste Lipidnanopartikel: Herstellung, Charakterisierung, Arzneistoffinkorporation und -freisetzung, Sterilisation und Lyophilisation, Ph.D. Thesis, Free University of Berlin, 1995.
  20. Cavalli, 1998, The effect of the components of microemulsions on both size and crystalline structure of solid lipid nanoparticles (SLN) containing a series of model molecules, Pharmazie, 53, 392
  21. Lukyanov, 1994, Autoclaving of liposomes, J. Microencapsul., 11, 669, 10.3109/02652049409051118 · doi:10.3109/02652049409051118
  22. Schwarz, 1995, Sterilization and physical stability of drug-free and etomidate-loaded solid lipid nanoparticles, Proc. Intern. Symp. Control. Rel. Bioct. Mater., 22, 766
  23. Liedtke, 1999, Physical characterisation of solid lipid nanoparticles (SLN™), Proc. Intern. Symp. Control. Rel. Bioact. Mater., 26, 599
  24. J.S. Lucks, Parenterale Fettemulsionen als Arzneistoffträger — Herstellung, Charakterisierung und Stabilität, Ph.D. Thesis, Christian Albrechts Universität Kiel, 1993.
  25. C. Freitas, Feste Lipid-Nanopartikel (SLN): Mechanismen der physikalischen Destabilisierung und Stabilisierung, Ph.D. Thesis, Free University of Berlin, 1998.
  26. Crowe, 1992, Stabilization of dry liposomes by carbohydrates, Dev. Biol. Stand., 74, 285
  27. Bensouda, 1989, Freeze-drying of emulsions — influence of congealing on granulometry — research of a cryoprotectant agent, Pharm. Acta Helv., 64, 40
  28. Strauss, 1986, The interaction of saccharides with lipid bilayer vesicles: stabilization during freeze-thawing and freeze-drying, Biochim. Biophys. Acta, 858, 169, 10.1016/0005-2736(86)90303-2 · doi:10.1016/0005-2736(86)90303-2
  29. Ausborn, 1992, Stabilization of liposomes by freeze–thaw and lyophilization techniques: problems and opportunities, Eur. J. Pharm. Biopharm., 38, 133
  30. Hauser, 1988, Stabilization of small, unilamellar phospholipid vesicles by sucrose during freezing and dehydration, Adv. Exp. Med. Biol., 238, 71, 10.1007/978-1-4684-7908-9_7 · doi:10.1007/978-1-4684-7908-9_7
  31. Vemuri, 1991, Effect of sugars on freeze–thaw and lyophilization of liposomes, Drug Dev. Ind. Pharm., 17, 327, 10.3109/03639049109043831 · doi:10.3109/03639049109043831
  32. Shulkin, 1984, Lyophilized liposomes: a new method for long-term vesicular storage, J. Microencapsul., 1, 73, 10.3109/02652048409031539 · doi:10.3109/02652048409031539
  33. Siekmann, 1994, Melt-homogenized solid lipid nanoparticles stabilized by the nonionic surfactant tyloxapol. II. Physicochemical characterization and lyophilisation, Pharm. Pharmacol. Lett., 3, 225
  34. Häberle, 1992, In situ investigations of single living cells infected by viruses, Ultramicroscopy, 1161, 42
  35. Shakesheff, 1994, Visualizing the degradation of polymer surfaces with an Atomic Force Microscope, Proc. Intern. Symp. Control. Rel. Bioact. Mat., 21, 1343
  36. A. Dingler, Feste Lipid-Nanopartikel als kolloidale Wirkstoffträgersysteme zur dermalen Applikation, Ph.D. Thesis, Free University of Berlin, 1998.
  37. Anger, 1999, High resolution size determination of 20nm colloidal gold particles by SedFFF, Pharm. Res., 16, 1743, 10.1023/A:1018962217258 · doi:10.1023/a:1018962217258
  38. Anger, 2000, Charakterisierung von makromolekülen, kolloiden und partikeln mit der field flow fractionation, Pharm. Ind., 62, 150
  39. Anger, 1999, Coating of nanoparticles: analysis of adsorption using sedimentation field–flow fractionation (SdFFF), Proc. Intern. Symp. Control. Rel. Bioact. Mater., 26, 599
  40. V. Jenning, Feste Lipid Nanopartikel als Trägersystem für die dermale Applikation von Retinol, Ph.D. Thesis, Free University of Berlin, 1999.
  41. Zimmermann, 1999, H-NMR as a method to characterize colloidal carrier systems, Proc. Intern. Symp. Control. Rel. Bioact. Mater., 26, 595
  42. H. Weyers, Feste Lipid Nanopartikel (SLN) für die gewebsspezifische Arzneistoffapplikation — Herstellung und Charakterisierung oberflächenmodifizierter Formulierungen, Ph.D. Thesis, Free University of Berlin, 1995.
  43. Siekmann, 1994, Electron-microscopic characterization of melt-homogenised solid lipid nanoparticles, Eur. J. Pharm. Sci., 2, 190, 10.1016/0928-0987(94)90459-6 · doi:10.1016/0928-0987(94)90459-6
  44. Yoshino, 1983, Influence of the fatty acid composition on the properties and polymorphic transition of fatty suppository bases, Chem. Pharm. Bull., 31, 237, 10.1248/cpb.31.237 · doi:10.1248/cpb.31.237
  45. Rapoport, 1998, Effect of Pluronic on the intracellular distribution and intracellular dynamics of a spin-labeled analog of doxorubicin, Proc. Intern. Symp. Control. Rel. Bioact. Mater., 26, 1052
  46. Ahlin, 2000, Influence of spin probe structure on its distribution in SLN dispersions, Int. J. Pharm., 196, 241, 10.1016/S0378-5173(99)00431-7 · doi:10.1016/s0378-5173(99)00431-7
  47. Cavalli, 1992, Behaviour of timolol incorporated in lipospheres in the presence of a series of phosphate esters, S.T.P. Pharma Sci., 2, 514
  48. Gasco, 1992, Timolol in lipospheres, Pharmazie, 47, 119
  49. Cavalli, 1995, Preparation and evaluation in vitro of colloidal lipospheres containing pilocarpine as ion pair, Int. J. Pharm., 117, 243, 10.1016/0378-5173(94)00339-7 · doi:10.1016/0378-5173(94)00339-7
  50. Morel, 1994, Incorporation in lipospheres of [D-Trp-6]LHRH, Int. J. Pharm., 105, R1, 10.1016/0378-5173(94)90466-9 · doi:10.1016/0378-5173(94)90466-9
  51. Lukowski, 1997, Electron diffraction of solid lipid nanoparticles loaded with aciclovir, Pharmazie, 52, 642
  52. S.A. Runge, Feste Lipidnanopartikel (SLN™) als kolloidaler Arzneistoffträger für die orale Applikation von Ciclosporin A, Ph.D. Thesis, Free University of Berlin, 1998.
  53. H. Bunjes, Einflußnahme unterschiedlicher Faktoren auf Struktur und Eigenschaften von Nanopartikeln aus festen Triglyceriden. Ph.D. Thesis, Friedrich-Schiller-Universität Jena, 1998.
  54. Ahlin, 1998, EPR study of loading capacity and location of spin-labelled lipophilic substance in different SLN, Proc. Int. Symp. Control. Rel. Bioact. Mater., 25, 334
  55. K. Mäder, Habilitation Thesis, Humboldt University Berlin, 1998.
  56. Metha, 1992, Fat emulsion particle-size distribution in total nutrient admixtures, Am. J. Hosp. Pharm, 49, 2749
  57. Puntis, 1992, Hazards of parenteral treatment: do particles count?, Arch. Dis. Child., 67, 1475, 10.1136/adc.67.12.1475 · doi:10.1136/adc.67.12.1475
  58. Blunk, 1993, Differential adsorption: Effect of plasma protein adsorption patterns on organ distribution of colloidal drug carriers, Proc. Intern. Symp. Control. Rel. Bioact. Mater., 20, 256
  59. Rudt, 1993, In vitro uptake of polystyrene latex particles and parenteral fat emulsions by human granulocytes, Int. J. Pharm., 99, 1, 10.1016/0378-5173(93)90315-7 · doi:10.1016/0378-5173(93)90315-7
  60. Müller, 1999, Solid lipid nanoparticles: phagocytic uptake, in vitro cytotoxicity and in vitro biodegradation, 1st communication, Pharm. Ind., 61, 462
  61. Cavalli, 1999, Albumin adsorption on stealth and non-stealth solid lipid nanoparticles, S.T.P. Pharma Sci., 9, 183
  62. Maaßen, 1993, Comparison of cytotoxicity between polyester nanoparticles and solid lipid nanoparticles, Proc. Intern. Symp. Control. Rel. Bioact. Mater., 20, 490
  63. Müller, 1996, Phagozytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407, J. Drug Target., 4, 161, 10.3109/10611869609015973 · DOI · Paper page
  64. Borgström, 1977, The polar interactions between pancreatic lipase, colipase and the triglyceride substrate, FEBS Lett., 83, 23, 10.1016/0014-5793(77)80633-9 · doi:10.1016/0014-5793(77)80633-9
  65. Müller, 1999, Solid lipid nanoparticles: phagocytic uptake, in vitro cytotoxicity and in vitro biodegradation, 2nd communication, Pharm. Ind., 61, 564

Cited by

See all 981

Metadata

Authors
Mehnert, W., & Mäder, K.
Venue
Advanced Drug Delivery Reviews
Publisher
Elsevier BV
Published
2012-12
Volume
64
Pages
83-101
ISSN
0169-409X (ISSN-L)
OpenAlex
W1987433127
Cited by
981
References
108
FWCI
4.77
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.